Vendor Inspections Hold Up Wright's Augment Graft Approval
This article was originally published in The Gray Sheet
Executive Summary
Wright received an "approvable" letter from FDA about nine months ago for its Augment biologic-device bone graft, but the approval is delayed as the agency performs multiple inspections and has issued two Form-483s to a component supplier for the product.